Enterprise Dynamic
Neurosurgery Frontier News showed that, reviewed and approved by Ethics Committee of Beijing Tiantan Hospital, Capital Medical University (Ethics Review Number YW2018-018-01/02/03), chaired by Profess...
[View details]
A Randomized, Controlled, Open-label, Multicenter, Phase II/III Clinical Trial to Evaluate the Safety and Efficacy of Chlorogenic Acid for Injection in the Treatment of Recurrent Grade IV Glioblastoma...
[View details]
The clinical trial “A Randomized, Controlled, Open-label, Multicenter, Phase II/III Clinical Trial to Evaluate the Safety and Efficacy of Chlorogenic Acid for Injection in the Treatment of Recurrent G...
[View details]
The Third China BioMed Innovation and Investment Conference was held at the Suzhou BioBay Conference Center on September 18, 2018. At the conference, Jiuzhang Biotech Company presented a special repor...
[View details]